Literature DB >> 9198128

Insights into selectin function from knockout mice.

P S Frenette1, D D Wagner.   

Abstract

The development of animal models through gene targeting was very useful to the selectin field. Selectins are found on endothelium, platelets and leukocytes and, they mediate adhesion among these cell types. The removal of a single selectin gene taught us that P-selectin on the vessel wall mediates leukocyte rolling in the absence of inflammation and that all three selectins contribute to leukocyte rolling during inflammation. Similarly, P-selectin is responsible for early neutrophil recruitment while the other selectins contribute in later stages. The knockout animals also confirmed the important role of L-selectin in lymphocyte homing. Removal of both endothelial selectins uncovered the hidden importance of E-selectin in leukocyte homeostasis and showed that the endothelial selectins were as important for leukocyte extravasation as the leukocyte beta 2 integrins. The submission of selectin-deficient mice to models of various human diseases can provide invaluable information on conditions in which an anti-selectin therapy may prove beneficial.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9198128

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  26 in total

1.  The significance of platelet activation in rheumatoid arthritis.

Authors:  Feng Wang; Nian-Song Wang; Chun-Gen Yan; Jun-Hui Li; Ling-Quan Tang
Journal:  Clin Rheumatol       Date:  2007-02-06       Impact factor: 2.980

2.  Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

Authors:  A Koenig; K Norgard-Sumnicht; R Linhardt; A Varki
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Down-modulation of L-selectin by lipopolysaccharide is not required for lipopolysaccharide-induced expression of CD14 in mouse bone marrow granulocytes.

Authors:  T Pédron; R Girard; R Chaby
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin.

Authors:  Yanguang Gao; Min Wei; Sheng Zheng; Xueqing Ba; Shui Hao; Xianlu Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-06       Impact factor: 4.553

5.  An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation.

Authors:  Akiko Shigeta; Masanori Matsumoto; Thomas F Tedder; John B Lowe; Masayuki Miyasaka; Takako Hirata
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

6.  Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients.

Authors:  Oluwagbemiga O Ayoola; Rahman A Bolarinwa; Uvie U Onakpoya; Tewogbade A Adedeji; Chidiogo C Onwuka; Bukunmi M Idowu
Journal:  Blood Adv       Date:  2018-11-27

7.  Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.

Authors:  Lianchun Wang; Jillian R Brown; Ajit Varki; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 8.  An integrated view of L-selectin and trophinin function in human embryo implantation.

Authors:  Michiko N Fukuda; Kazuhiro Sugihara
Journal:  J Obstet Gynaecol Res       Date:  2008-04       Impact factor: 1.730

9.  The combined role of P- and E-selectins in atherosclerosis.

Authors:  Z M Dong; S M Chapman; A A Brown; P S Frenette; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation.

Authors:  Pieter R Norden; Amélie Sabine; Ying Wang; Cansaran Saygili Demir; Ting Liu; Tatiana V Petrova; Tsutomu Kume
Journal:  Elife       Date:  2020-06-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.